Shalby Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 07, 2024 at 03:58 am
Share
Shalby Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 2,160.47 million compared to INR 2,024.6 million a year ago. Revenue was INR 2,205.66 million compared to INR 2,065.01 million a year ago. Net income was INR 190.71 million compared to INR 152.86 million a year ago. Basic earnings per share from continuing operations was INR 1.78 compared to INR 1.42 a year ago. Diluted earnings per share from continuing operations was INR 1.78 compared to INR 1.41 a year ago.
For the nine months, sales was INR 6,895.16 million compared to INR 6,059.38 million a year ago. Revenue was INR 7,039.53 million compared to INR 6,192.78 million a year ago. Net income was INR 674.77 million compared to INR 538.02 million a year ago. Basic earnings per share from continuing operations was INR 6.28 compared to INR 5 a year ago. Diluted earnings per share from continuing operations was INR 6.28 compared to INR 4.98 a year ago.
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company operate through three main verticals: hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise and implant business. The Company is engaged in the arthroplasty segment. It has its presence across tertiary and quaternary specialties including cardiology, neurology, oncology and cardiac. SOCE offers a comprehensive orthopedic center with easy access and treatment for all orthopedic-related issues, including joint replacement surgery, at affordable rates. The Company encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and more.